
A disease-modifying therapy for stage 3 T1D, a second once-weekly insulin, and automated insulin delivery for T2D mark a busy year in diabetes care.
The Pharmacy Compounding Accreditation Board, Attentus Medical Sales Inc, and VGM and Associates will host a series of free webinars to discuss the implications of the recently released hazardous drug safety standards by the United States Pharmacopeial Convention USP .
The Pharmacy Compounding Accreditation Board, Attentus Medical Sales Inc, and VGM and Associates will host a series of free webinars to discuss the implications of the recently released hazardous drug safety standards by the United States Pharmacopeial Convention USP <800>.






